Comerica Bank’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Comerica Bank’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$517K	Sell	4,569 -969	-17%	-$80.5K	﹤0.01%	1759
2022 Q3	$352K	Sell	5,538 -18,381	-77%	-$1.28M	﹤0.01%	1901
2022 Q2	$2.02M	Buy	23,919 +8,184	+52%	+$775K	0.02%	1092
2022 Q1	$1.82M	Buy	15,735 +1,463	+10%	+$143K	0.01%	1215
2021 Q4	$1.24M	Buy	14,272 +8,914	+166%	+$972K	0.01%	1459
2021 Q3	$624K	Sell	5,358 -50,925	-90%	-$5.29M	﹤0.01%	1870
2021 Q2	$5.81M	Sell	56,283 -29,469	-34%	-$2.71M	0.03%	629
2021 Q1	$8.11M	Buy	85,752 +12,992	+18%	+$1.1M	0.05%	458
2020 Q4	$5.66M	Buy	72,760 +64,163	+746%	+$4.77M	0.04%	622
2020 Q3	$666K	Buy	8,597 +1,003	+13%	+$69K	﹤0.01%	1783
2020 Q2	$456K	Buy	7,594 +508	+7%	+$21.7K	﹤0.01%	1903
2020 Q1	$236K	Buy	7,086 +205	+3%	+$6.94K	﹤0.01%	2033
2019 Q4	$241K	Buy	+6,881	New	+$211K	﹤0.01%	2137
2017 Q2	–	Sell	-63,484	Closed	-$983K	–	2234
2017 Q1	$983K	Sell	63,484 -468	-0.7%	-$7.58K	0.01%	1615
2016 Q4	$1.11M	Buy	63,952 +31,703	+98%	+$575K	0.01%	1527
2016 Q3	$611K	Sell	32,249 -1,491	-4%	-$29.1K	0.01%	1710
2016 Q2	$763K	Sell	33,740 -739	-2%	-$12K	0.01%	1635
2016 Q1	$510K	Buy	34,479 +404	+1%	+$7.07K	﹤0.01%	1754
2015 Q4	$647K	Buy	34,075 +399	+1%	+$7.77K	0.01%	1612
2015 Q3	$667K	Sell	33,676 -89,922	-73%	-$2.84M	0.01%	1606
2015 Q2	$4.29M	Buy	123,598 +57,856	+88%	+$1.77M	0.02%	1045
2015 Q1	$1.71M	Buy	+65,742	New	+$1.21M	0.01%	1186

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Comerica Bank's HZNP Position: Q4 2022 in Review

Comerica Bank reduced its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 17% in Q4 2022, selling an estimated $80.5K and leaving 4,569 shares worth $517K. The position accounts for ﹤0.01% of the portfolio, ranked #1759.

Comerica Bank first reported a position in HZNP in Q1 2015 and has held it in 22 quarters since. The position peaked at $8.11M in Q1 2021. 613 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

Comerica Bank held 4,569 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $517K as of Q4 2022.
Comerica Bank sold 969 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $80.5K.
Horizon Therapeutics Public Limited Company Ordinary Shares made up ﹤0.01% of Comerica Bank's portfolio in Q4 2022, its #1759 holding.
Comerica Bank first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2015 and has held it in 22 quarters since.
Comerica Bank's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $8.11M in Q1 2021.
613 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Comerica Bank's 13F filing for Q4 2022, filed 26 Jan 2023.